INCREASES IN SERUM-LIPIDS DURING PREGNANCY IN TYPE-1 DIABETIC WOMEN WITH NEPHROPATHY

被引:3
作者
BIESENBACH, G
JANKO, O
STOGER, H
ZAZGORNIK, J
机构
[1] Second Department of Medicine, Section of Nephrology, General Hospital Linz
[2] Department of Obstetrics and Gynecology, General Hospital Linz
关键词
DIABETIC PREGNANCY; NEPHROTIC SYNDROME; HYPERLIPEMIA;
D O I
10.1111/j.1464-5491.1994.tb00269.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During pregnancy women with Type 1 diabetes do not differ from normal women with respect to pregnancy-associated changes in serum lipid levels. However influence of diabetic nephropathy on lipoprotein metabolism in pregnancy has not been described previously. Changes in lipids were compared during and after pregnancy in 10 Type 1 diabetic women without macroproteinuria as well as in 5 diabetic women with macroproteinuria due to diabetic nephropathy. In the pregnant women with macroproteinuria, compared to the diabetic women without macroproteinuria, we observed both significantly higher total and percent increases in serum levels of total cholesterol (97 % versus 48 %) and of LDL-cholesterol (137 % versus 50 %), which had risen progressively throughout gestation. The percent increases in serum triglycerides (115 % versus 128 %) were similar in both patient groups. Metabolic control was improved during pregnancy in both groups of women. Renal function remained normal throughout pregnancy in the diabetic women without nephropathy and worsened during pregnancy in the proteinuric women. The mean protein excretion showed a physiological rise from 0.107 +/- 0.040 g 24 h-1 before pregnancy to 0.336 +/- 0.234 g 24 h-1 in the third trimester in the non-proteinuric women, and an increase from 2.2 +/- 1.0 to 7.1 +/- 1.7 g 24 h-1 during the same period in the women with macroproteinuria. Therefore, it is concluded that the greater increase in serum lipid levels during pregnancy in the women with pre-existing diabetic nephropathy can mainly be explained by the concomitant increase in proteinuria associated with development of the nephrotic syndrome in these patients.
引用
收藏
页码:262 / 267
页数:6
相关论文
共 32 条
[1]  
de Alvarez RR, Gaiser DF, Simkins DM, Smith EK, Bratvold GE., Serial studies of serum lipids in normal pregnancy, Am J Obstet Gynecol, 77, pp. 743-757, (1959)
[2]  
Warth MR, Arky RA, Knopp RH., Lipoprotein metabolism in pregnancy. Altered lipid composition in intermediate, very low, low and high density lipoprotein fractions, J Clin Endocrin Metab, 41, pp. 649-655, (1975)
[3]  
Hollingsworth DR, Grundy SM., Pregnancy‐associated hypertriglyceridemia in normal and diabetic women, Diabetes, 31, pp. 1092-1097, (1982)
[4]  
Hillman L., Schonfeld G., Miller JP, Wulff G., Apolipoproteins in human pregnancy, Metabolism, 24, pp. 943-952, (1975)
[5]  
McDonald-Gibson RG, Young M., Hytten FE., Changes in plasma non‐esterfied fatty acids and serum glycerol in pregnancy, BJOG: An International Journal of Obstetrics and Gynaecology, 82, pp. 460-466, (1975)
[6]  
Brockerhoff PG., Hyperlipoproteinemia in gestation, Fortschr Med, 104, pp. 277-279, (1986)
[7]  
Feingold KR, Wiley T., Moser AH, Lear SR, Wiley MH., De novo cholesterogenesis in pregnancy, J Lab Clin Med, 101, pp. 256-263, (1980)
[8]  
Feingold KR, Wiley MH, MacRae G., Siperstein MD., Mevalonate metabolism in pregnant rats, Metabolism, 29, pp. 885-891, (1980)
[9]  
Wallentin L., Fahraeus L., Cholesterol sterification rate and its relation to lipoprotein levels in plasma in normal pregnancy, J Lab Clin Med, 107, pp. 216-220, (1986)
[10]  
Vernet A., Smith EB., Lipoprotein pattern in diabetes and the changes occurring during pregnancy, Diabetes, 10, pp. 345-350, (1961)